Mark Robert Litzow

159PUBLICATIONS
534CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Additive manufacturing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (159)

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|Jul 25, 2026
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

|Feb 24, 2026
Immunotherapy in the up-front treatment of adult B-cell precursor acute lymphoblastic leukemia: when, how, who?

Soumyadeep Datta, Mark R Litzow

|Feb 19, 2026
Incremental changes to improve outcomes in ALL.

Mark R Litzow

|Feb 18, 2026
CRLF2 rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link?

Flavia Gava, Bonnie Yates, Zhouxin Sun

Pageof 27

Frequent Collaborators

55 joint publications

Mrinal S Patnaik

40 joint publications

Mithun Vinod Shah

37 joint publications

Naseema Gangat

34 joint publications

William Joseph Hogan